Identification of <i>NTRK</i> fusions in pediatric mesenchymal tumors

Abstract

NTRK fusions occur in a subset of young patients with mesenchymal or sarcoma-like tumors at a low frequency, and are eminently druggable targets via either investigational agents or approved drugs.